Fits like an invisible glove over the current standard of care procedures and captures key longitudinal and outcome data.
This allows clinical teams to proceed without any changes to their clinical with us to capture key longitudinal and outcome data. We believe our technology will be part of the standard-of-care to annually predict outcomes for 250,000 brain tumor, epilepsy, stroke and traumatic brain injury patients within a decade.